五大联赛外围

欧冠联赛竞猜平台

欧冠联赛竞猜平台

Our leadership, which includes our Board of Directors and Senior Executive Team, is accountable to our shareholders for the responsible conduct of the business and our long-term success. It also represents the interests of all our stakeholders in ensuring that we deliver for patients by putting science at the heart of everything we do.

欧冠联赛竞猜平台

欧冠联赛竞猜平台

Our Directors are collectively responsible for the success of AstraZeneca. In addition, the Non-Executive Directors are responsible for exercising independent and objective judgement and for scrutinising and challenging management. The Board is responsible for setting our strategy and policies, oversight of risk and corporate governance and monitoring progress towards meeting our annual plans. It is accountable to our shareholders for the proper conduct of the business and our long-term success and represents the interests of all stakeholders. The Board has delegated some of its powers to four principal committees and the CEO. Members of the Board and their biographies are shown below.

德甲联赛竞猜平台

Leif Johansson Non-Executive Chairman of the Board 欧冠联赛竞猜平台

Member of the Board since April 2012 and Chairman since June 2012.

Read biography
英超竞彩app

Pascal Soriot Executive Director and Chief Executive Officer 欧冠联赛竞猜平台

Member of the Board and CEO since October 2012.

Read biography
西甲竞猜平台app

Marc Dunoyer Executive Director and Chief Financial Officer 欧冠联赛竞猜平台

Member of the Board and CFO since November 2013.

Read biography

   

欧冠联赛竞猜平台

欧冠联赛竞猜平台

In addition to the Board of Directors, our Senior Executive Team, or SET, is the body through which our Chief Executive Officer (CEO) exercises the authority delegated to him by the Board. Our CEO leads the SET and has executive responsibility for the management, development and performance of the business. The Chief Executive Officer, Chief Financial Officer and SET also take the lead in developing our strategy for review, constructive challenge and approval by the Board as part of our annual strategy review process.

意甲联赛下注

Pascal Soriot Executive Director and CEO 欧冠联赛竞猜平台

Read biography
德甲竞猜平台网站

Marc Dunoyer Executive Director and CFO 欧冠联赛竞猜平台

Read biography
西甲竞猜

Katarina Ageborg Executive Vice-President, Sustainability and Chief Compliance Officer; President AstraZeneca AB, Sweden 欧冠联赛竞猜平台

Read biography
2020欧洲杯竞猜平台

José Baselga Executive Vice-President, Oncology R&D 欧冠联赛竞猜平台

Read biography
德甲联赛官方平台

Pam Cheng Executive Vice-President, Operations and Information Technology 欧冠联赛竞猜平台

Read biography
意甲竞猜平台app

Fiona Cicconi Executive Vice-President, Human Resources 欧冠联赛竞猜平台

Read biography
欧洲杯联赛外围

Ruud Dobber Executive Vice-President, BioPharmaceuticals Business Unit 欧冠联赛竞猜平台

Read biography
意甲竞猜平台

David Fredrickson Executive Vice-President, Oncology Business Unit 欧冠联赛竞猜平台

Read biography
意甲竞猜平台

Menelas (Mene) Pangalos Executive Vice-President, BioPharmaceuticals R&D 欧冠联赛竞猜平台

Read biography
德甲现金竞猜

Jeff Pott General Counsel 欧冠联赛竞猜平台

Read biography
欧冠联赛竞猜平台

Iskra Reic Executive Vice-President, Europe and Canada 欧冠联赛竞猜平台

Read biography
欧冠下注app

Leon Wang Executive Vice-President, International 欧冠联赛竞猜平台

Read biography